Alaunos Therapeutics Inc.
TCRT | NASDAQ
$1.26
+$0.06 (+5.00%)
At close: Sep 21, 2026, 4:00 PM ET
$1.23
-$0.03 (-2.38%)
Pre-market:
Sep 22, 2026, 6:13 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.47 | -0.65 | -0.48 | -3.75 | -3.04 | -6.70 |
PEG Ratio | 0.06 | 0.01 | 0.03 | 0.07 | 0.65 | 0.10 |
PS Ratio | 1.26K | 305.84 | 3.39K | 48.24 | 587.17 | n/a |
PB Ratio | 2.92 | 1.48 | 2.69 | 3.66 | 4.03 | 4.26 |
P/FCF Ratio | -2.12 | -0.62 | -0.56 | -4.79 | -3.61 | -7.91 |
P/OCF Ratio | -2.19 | -0.62 | -0.56 | -4.82 | -3.80 | -9.27 |
OCF/S Ratio | -57.38K | -49.71K | -602.84K | -1K | -15.44K | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | 0.52 | 0.52 | 0.04 |
Quick Ratio | 2.45 | 3.98 | 4.22 | 1.65 | 4.91 | 7.11 |
Current Ratio | 2.45 | 3.98 | 4.22 | 2.23 | 4.91 | 7.11 |
Asset Turnover | 0 | 0 | 0 | 0.04 | 0 | n/a |
Interest Coverage | n/a | n/a | -17.84 | -11.13 | -65.22 | n/a |
Return on Equity | -193.96% | -226.81% | -557.16% | -97.86% | -135.64% | -64.51% |
Return on Assets | -140.80% | -169.84% | -425.27% | -58.10% | -83.01% | -54.65% |
Return on Invested Capital | -196.24% | -233.25% | -543.32% | -59.85% | -87.97% | -62.39% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -27.16K% | -3.52K% | -95.96K% | -670.64% | -11.78K% | n/a |
Net Profit Margin | -83.52K% | -46.79K% | -702.8K% | -1.29K% | -19.79K% | n/a |
Pretax Profit Margin | -83.52K% | -46.79K% | -702.8K% | -1.29K% | -19.79K% | n/a |
Operating Profit Margin | -84.5K% | -48.12K% | -685.34K% | -1.2K% | -19.48K% | n/a |
FCF Margin | -59.34K% | -49.71K% | -606.78K% | -1.01K% | -16.28K% | n/a |
EBITDA Margin | -83.38K% | -46.77K% | -618.08K% | -1.09K% | -18.84K% | n/a |
Add to Watchlist
Select watchlists to add or remove TCRT